Talis Biomedical Corp.
TLISUS $
-0.29 -4.12%
Premarket
$ 6.75
Before Hours Volume: 2.93K
| Close | Chg | Chg % |
|---|---|---|
| $7.04 | -0.26 | -3.56% |
Volume: 105.18K 65 Day Avg: 342.59K
6.98 Day Range 7.20
6.81 52 Week Range 33.90
Overview
TLIS Overview
Key Data
- Open $7.18
- Day Range 6.98 - 7.20
- 52 Week Range 6.81 - 33.90
- Market Cap $391.1M
- Shares Outstanding 25.69M
- Public Float 21.73M
- Beta 1.53
- Rev. per Employee $80.43K
- P/E Ratio N/A
- EPS -$3.23
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 1.28M 09/15/21
- % of Float Shorted 5.89%
- Average Volume 342.59K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
Analyst Ratings
Number of Ratings 3 Full Ratings
Recent News
Talis Biomedical downgraded to neutral from overweight at JPMorgan, price target to $10 from $17
Talis Biomedical started at overweight with $18 stock price target at J.P. Morgan
BTIG Thinks Talis Biomedical’s Stock is Going to Recover
on TipRanks.com
4 Stocks With High Insider Cluster Buys During February and March
on GuruFocus.com
Talis Biomedical Corp.
Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.